Tomorrow Abbvie will publish it's past quarter's results. Over the current book year the total revenue will be 28,02 billion USD (consensus estimates). This is slightly more than 2016's revenue of 25,64 billion USD.
The analysts expect for 2018 a net profit of 8,91 billion USD. For this year the consensus of the result per share is a profit of 5,56 USD. With this the price/earnings-ratio is 18,95.
Per share the analysts are expecting a dividend of 2,57 USD per share. Abbvie's dividend yield thus equals 2,44 percent. The average dividend yield of the biotech companies is a moderate 0,06 percent.
Abbvie's market capitalization is around 169,65 billion USD. On Monday the stock closed at 105,38 USD.ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.